Mirum Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-06-04

Reporting Person: Heron Patrick J (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-04	Stock Option (right to buy)	$16.88	A	17000	Acquired	2031-06-03	Common Stock (17000)	Direct

Footnotes

F1: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting.